125 related articles for article (PubMed ID: 35228177)
1. Controlled release floating drug delivery system for proton pump inhibitors lansoprazole: In-vitro, In-vivo floating and pharmacokinetic evaluation.
Murad S; Mudassir J; Faiz S; Zahra A; Usman F; Farhan M; Arshad MS; Abbas N; Hussain A; Faran Ashraf Baig MM
Pak J Pharm Sci; 2022 Jan; 35(1(Supplementary)):195-201. PubMed ID: 35228177
[TBL] [Abstract][Full Text] [Related]
2. Development of Dexlansoprazole Delayed-Release Capsules, a Dual Delayed-Release Proton Pump Inhibitor.
Grady H; Murakawa Y; Mulford D; Kukulka M
J Pharm Sci; 2019 Nov; 108(11):3496-3501. PubMed ID: 31386865
[TBL] [Abstract][Full Text] [Related]
3. Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.
Fang Y; Wang G; Zhang R; Liu Z; Liu Z; Wu X; Cao D
AAPS PharmSciTech; 2014 Jun; 15(3):513-21. PubMed ID: 24590548
[TBL] [Abstract][Full Text] [Related]
4. A clinical study to examine the potential effect of lansoprazole on the pharmacokinetics of bosutinib when administered concomitantly to healthy subjects.
Abbas R; Leister C; Sonnichsen D
Clin Drug Investig; 2013 Aug; 33(8):589-95. PubMed ID: 23839484
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic/Pharmacodynamic Evaluation of Dexlansoprazole Infusion Injection Compared with Lansoprazole in Healthy Chinese Adults.
Wu L; Liu J; Zheng Y; Zhai Y; Lin M; Wu G; Lv D; Shentu J
Clin Drug Investig; 2019 Oct; 39(10):953-965. PubMed ID: 31338800
[TBL] [Abstract][Full Text] [Related]
6. Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.
Vakily M; Lee RD; Wu J; Gunawardhana L; Mulford D
Clin Drug Investig; 2009; 29(1):35-50. PubMed ID: 19067473
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of lansoprazole and its main metabolites after single and multiple intravenous doses in healthy Chinese subjects.
Zhang D; Zhang Y; Liu M; Wang X; Yang M; Han J; Liu H
Eur J Drug Metab Pharmacokinet; 2013 Sep; 38(3):209-15. PubMed ID: 23229306
[TBL] [Abstract][Full Text] [Related]
8. [THE FEATURES OF SECRETION AND STOMACH MOTOR PROCESSES IN PATIENTS WITH DUODENAL ULCERS AS A CAUSE FOR REDUCING BIOAVAILABILITY OF PROTON PUMP INHIBITORS].
Serebrova SY; Zhuravleva MV; Prokofiev AB; Starodubtsey A K
Eksp Klin Gastroenterol; 2015; (9):8-13. PubMed ID: 26931004
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of pH-sensitive methyl methacrylate-g-starch/hydroxypropylated starch hydrogels: in vitro and in vivo study on release of esomeprazole magnesium.
Kumar P; Ganure AL; Subudhi BB; Shukla S
Drug Deliv Transl Res; 2015 Jun; 5(3):243-56. PubMed ID: 25787732
[TBL] [Abstract][Full Text] [Related]
10. Profiling biopharmaceutical deciding properties of absorption of lansoprazole enteric-coated tablets using gastrointestinal simulation technology.
Wu C; Sun L; Sun J; Yang Y; Ren C; Ai X; Lian H; He Z
Int J Pharm; 2013 Sep; 453(2):300-6. PubMed ID: 23806811
[TBL] [Abstract][Full Text] [Related]
11. Novel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluation.
Alai M; Lin WJ
AAPS J; 2014 May; 16(3):361-72. PubMed ID: 24519468
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of two lansoprazole delayed release capsules 30 mg in healthy male volunteers under fasting, fed and fasting-applesauce conditions: a partial replicate crossover study design to estimate the pharmacokinetics of highly variable drugs.
Thota S; Khan SM; Tippabhotla SK; Battula R; Gadiko C; Vobalaboina V
Drug Res (Stuttg); 2013 Nov; 63(11):551-7. PubMed ID: 23780504
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole-sulfide, pharmacokinetics of this promising anti-tuberculous agent.
Mdanda S; Baijnath S; Shobo A; Singh SD; Maguire GEM; Kruger HG; Arvidsson PI; Naicker T; Govender T
Biomed Chromatogr; 2017 Dec; 31(12):. PubMed ID: 28623874
[TBL] [Abstract][Full Text] [Related]
14. Formulation, optimization, and in-vitro-ex-vivo evaluation of dual-crosslinked zinc pectinate-neem gum-interpenetrating polymer network mediated lansoprazole loaded floating microbeads.
Rajput K; Tawade S; Nangare S; Shirsath N; Bari S; Zawar L
Int J Biol Macromol; 2022 Dec; 222(Pt A):915-926. PubMed ID: 36181884
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials.
Vakily M; Zhang W; Wu J; Atkinson SN; Mulford D
Curr Med Res Opin; 2009 Mar; 25(3):627-38. PubMed ID: 19232037
[TBL] [Abstract][Full Text] [Related]
16. Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations.
Alai M; Lin WJ
Int J Nanomedicine; 2015; 10():4029-41. PubMed ID: 26124659
[TBL] [Abstract][Full Text] [Related]
17. A novel once daily microparticulate dosage form comprising lansoprazole to prevent nocturnal acid breakthrough in the case of gastro-esophageal reflux disease: preparation, pharmacokinetic and pharmacodynamic evaluation.
Alai M; Lin WJ
J Microencapsul; 2013; 30(6):519-29. PubMed ID: 23294453
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers.
Niioka T; Miura M; Uno T; Yasui-Furukori N; Hayakari M; Tateishi T; Suzuki T
Eur J Clin Pharmacol; 2008 May; 64(5):503-9. PubMed ID: 18224311
[TBL] [Abstract][Full Text] [Related]
19. Uneven Distribution of Microgranules in Divided Lansoprazole Tablets.
Teitelbaum GA; Teitelbaum JE
J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):437-9. PubMed ID: 25885882
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
